Methods of Protein Detection in Cancer for Diagnosis, Prognosis and Therapy
Open Access
- 23 June 2022
- book chapter
- Published by IntechOpen
Abstract
Emerging proteomic technologies offer new insight in the study of malignant tumor to identify protein biomarkers for early detection, stratification, prediction and monitoring of treatment, as well as to detect target molecules for therapy. The tumor protein biomarker is responsible for the regulation of the cell cycle to promote cell proliferation and resistance to cell death. Important technologies include ELISA, immunohistochemistry, flow cytometry, western blot, mass spectrometry, protein microarray, and microfluidics for the study of screening, protein profiling, identification, qualitative and quantitative analysis of differential expressed oncoproteins relative to cancer tissues, counterparts at different stages of the disease from preneoplasia to neoplasia. It can also provide a detailed description of identifying tissue-specific protein biomarkers and to analysis the modification of protein activity in cancer conditions. In this chapter, we discuss current and emerging protein assays for improving cancer diagnosis, including trends toward advances in assay miniaturization, improve sensitivity and specificity, time and cost-effective, and accuracy in detection and measurement of protein activity. However, information from these protein diagnostic technologies should be integrated to obtain the optimal information required for the clinical management of a patient.Keywords
This publication has 125 references indexed in Scilit:
- Overcoming implementation challenges of personalized cancer therapyNature Reviews Clinical Oncology, 2012
- Predictive clinical outcome of the intratumoral CD66b‐positive neutrophil‐to‐CD8‐positive T‐cell ratio in patients with resectable nonsmall cell lung cancerCancer, 2011
- Microfluidic electrochemical immunoarray for ultrasensitive detection of two cancer biomarker proteins in serumBiosensors and Bioelectronics, 2011
- PML protein analysis using imaging flow cytometryJournal of Clinical Pathology, 2010
- New serum biomarkers for detection of esophageal carcinoma using Matrix-assisted laser desorption/ionization time-of-flight mass spectrometryJournal of Cancer Research and Clinical Oncology, 2010
- Genomic and proteomic biomarkers for cancer: A multitude of opportunitiesBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2009
- The analysis of doxorubicin resistance in human breast cancer cells using antibody microarraysMolecular Cancer Therapeutics, 2006
- Protein microarrays: catching the proteomeMechanisms of Ageing and Development, 2005
- Characteristics of the Microplate Method of Enzyme-Linked Immunosorbent Assay for the Detection of Plant VirusesJournal of General Virology, 1977
- Enzyme-linked immunosorbent assay (ELISA) quantitative assay of immunoglobulin GImmunochemistry, 1971